ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 751393 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 751393; 2) Community: the network communities that were significantly associated with the response to NSC 751393; 3) Molecule: the relationships between components within communities and NSC 751393; 4) MDR: the compounds that were significantly associated with the NSC 751393.

NSC Compound Enrichment Correlation
NSC 164970 Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- 0.000706163530262832 0.32302405
NSC 671095 Null 0.000706163530262832 0.16487495
NSC 744469 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate 0.000706163530262832 0.57204098
NSC 610458 Camptothecin Derivative 0.000871592241209852 0.27356663
NSC 724598 S-(dipropylarsino)-3-mercapto-1,2-propanediol 0.000871592241209852 0.257549
NSC 736606 Null 0.000871592241209852 0.23644059
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.00094423800811012 0.44809879
NSC 718165 Null 0.00094423800811012 0.40082119
NSC 682561 Cardenolide 2 0.00104302631219553 0.42120913
NSC 3060 Arsenenous acid, potassium salt (9CI) 0.00182957917645007 0.39575915
Total:61  Current:2    [First] [Prev] [Next] [Last]